Recent studies suggest that TET1 is differentially expressed in different types of tumours and different subtypes of the same tumour and exhibits different biological effects by activating different genes in different signalling pathways, thus displaying both oncogene and antioncogene properties. This evidence concerns the gene TET1 and neoplasm.